Exo Therapeutics Inc.

https://www.exo-therapeutics.com

LinkedIn: https://www.linkedin.com/company/exorx

Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSight™ platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company's team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases. *

	Start	2018-01-01 established
	Industry	exosite drugs
	Industry 2	ExoSight™ platform
	Person	Bruce, Michael (Exo Therapeutics 202012 CEO)

	Region	Cambridge, MA
	Country	United States (USA)
	Street	700 Main Street Office 206
	City	02139 Cambridge, MA
		Address record changed: 2021-09-26

Basic data	Employees	n. a.

		* Document for »About Section«: Exo Therapeutics, Inc.. (12/16/20). "Press Release: Exo Therapeutics Launches with $25 Million Series A Financing to Unlock Intractable Drug Targets with Exosites". Cambridge, MA.

		Record changed: 2023-07-10